Viewing Study NCT06481566


Ignite Creation Date: 2025-12-24 @ 4:16 PM
Ignite Modification Date: 2026-05-29 @ 5:06 AM
Study NCT ID: NCT06481566
Status: RECRUITING
Last Update Posted: 2024-09-04
First Post: 2024-06-20
Is Gene Therapy: True
Has Adverse Events: False

Brief Title: Efficacy and Safety of Almonertinib Combined With Stereotactic Body Radiotherapy (SBRT) in the Treatment of Non-small Cell Lung Cancer With EGFR Sensitive Mutation: a Single-arm, Open-label Clinical Trial
Sponsor: Chongqing University Cancer Hospital
Organization:

Conditions & Keywords Data

Conditions:

Conditions

Condition Brief Condition Text View
None Non-small Cell Lung Cancer View
Keywords:

Keywords

Keyword Brief Keyword Text View
None Non-small cell lung cancer View
None Stereotactic Ablative Body Radiotherapy View
None EGFR-TKI View